Clinical Trial Update: Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1 and Phase 2 studies evaluating the immune response to yellow fever vaccination in adults with atopi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-09-30